GB2381195A

GB2381195A - Orchid essence containing medicaments for the treatment of stress

Info

Publication number: GB2381195A
Application number: GB0216201A
Authority: GB
Inventors: Clare G Harvey
Original assignee: Individual
Current assignee: Individual
Priority date: 2002-07-12
Filing date: 2002-07-12
Publication date: 2003-04-30
Also published as: GB0216201D0; GB0502850D0; AU2003250401A1; WO2004006944A1; GB2409645B; GB2409645A

Abstract

Orchid essence-containing medicaments comprise one or more orchid extracts and are strong mood enhancing agents capable of effectively relieving or reducing stress. The medicaments may also contain secondary flower essences, phytolaits (plant milks) and monoils. In one embodiment a stress treating formulation comprises Epidendrum chioneum and Miltonia phalaenopsis orchid extract, secondary flower essence e.g. Prunella vulgaris, and e.g. Citrus reticulata as essential oils. A preferred phytolait is extracted from acacia and jasmine flowers, whereas a preferred monoil is Tahitian coconut oil.

Description

Flower Essence-containing Medicaments This invention relates to the use of flower essence-containing medicaments, particularly those that are useful for the alleviation of stress. More particularly, though not exclusively, the invention relates to topical creams e. g. facial creams.

"Stress" is defined to be any interference that disturbs a person's healthy mental and physical well-being. A person may experience stress in response to a wide range of physical and emotional stimuli including physical violence, internal conflicts and significant life events such as death of a loved one, birth of a baby, or divorce. Some people are more susceptible than others to stress-related medical problems. When faced with a stressful situation the body responds by increasing production of certain hormones such as cortisol and adrenalin. These hormones lead to changes in heart rate, blood pressure, metabolism, and physical activity designed to improve overall performance. However, at a certain level, they disrupt an individual's ability to cope.

Continued exposure to stress often leads to mental and physical symptoms, such as anxiety and depression, indigestion, palpitations, and muscular aches and pains.

Various treatments are used to assist people suffering from stress, including pharmaceutical drug therapy, relaxation techniques such as yoga and meditation, and aromatherapy.

Aromatherapy involves a range of treatments using essential oils and flower essences that are extracted from plants. Essential oils are known to contain the plant actives that have a beneficial effect of repairing the cellular structure of the skin and helping to stimulate the growth of new cells; flower essences, on the other hand, are known as the flowers liquid energy and have the extraordinary ability directly to enhance and alter our emotional response to ourselves and the world, bringing relief from unsettling moods and emotions such as fear, anxiety, guilt, anger and melancholy, and helping with the development of a positive and stress-free attitude towards our life. It is well known that a happy self-image has a powerful physiological effect that adds to the inner glow of health and vitality. Many ancient civilizations, particularly the

Chinese, documented the use of such materials in treating different disorders, and some aromatherapy treatments are known to have effect on stress-related conditions.

Indeed, the Australian Aborigines practiced one of the most ancient forms of flower essence therapy. Around 10,000 years ago they were gathering dew-drenched flowers and either drinking the dew or placing the flowers in their mouths. If the flowers were inedible, then they would simply sit among them. They found that the flowers could restore a person's mental attitude. If someone were afraid, they would gain courage, if angry they would find peace, if sick would become well again. It is believed that Native Americans, Minoans and ancient Egyptians harnessed the healing powers of flowers in similar ways.

The Applicant has surprisingly found that medicaments, especially topical creams such as facial creams, comprising one or more orchid essences have strong mood enhancing properties and are thereby extremely effective at reducing stress levels in the human body. These highly beneficial properties of orchid essences were hitherto unknown.

Accordingly, the present invention provides the use of one or more orchid essences in the preparation of medicaments for reducing stress levels. In another aspect, there is provided a medicament that is a topical cream, such as a facial cream, comprising one or more orchid essences. The medicaments may optionally comprise one or more further non-orchid flower essences (hereafter termed"secondary flower essences") one or more essential oils, one or more phytolaits and one or more monoils.

Suitable orchid essences are selected from Acineta superba, Amazonas, Epidendrum secundum, Miltonia phalaenopsis, Oncidium incurvum, Stanhopea wardii, Oncidium lanceanum, Cymbidium lowianum, Epidendrum prismatocarpum, Cattleya warscewiczii, Vanda tricolor, Laeliocattleya hybr., Laeliocattleya anceps clara, Cattleya trianae, Oncidium abortivum, Paphiopedilum harrysianum, Paphiopedilum insigne, Epidendrum chioneum, Anguloa clowesii, Orchis mascula, Oncidium sphacelatum and Victoria amazonica.

Preferred orchid essences are selected from Epidendrum secundum, Miltonia phalaenopsis, Epidendrum chioneum, Anguloa clowesii, Oncidium sphacelatum, Amazonas, Cattleya warscewiczii and Oncidium abortivum.

The secondary flower essences are selected from Aesculus hippocastanum, Bromus ramosus, Rosa canina, Salix vitellina, RQ5 (Cherry plum, clematis, impatiens, Rock rose and Star of Bethlehem) and RQ8 (Cherry plum, clematis, impatiens, Rock rose, Star of Bethlehem Lotus and Self-heal) ; essences from cacti and succulent plants such as Caralluma russelliana, C, Cus pe'MV/anus, Ceropegiafusca, Cleistocactus ritterei, Cleistocactus stausii, Echinocactus grusonii, Echinocereus scheeri, Echinopsis oxygona, Ferocactus schwarzii, Hylocereus undatus, Mammillaria rubrograndis, Myitillocactus geometrizans, Opuntia cardiosperma, Opuntia dejecta, Orbea variegata, Pilosocereus pachycladus, Selenicereus grandiflorus, Seticereus icosagonus, Stenocereus marginatus and Stopelia desmetiana ; rose essences such as Rosa roxbourghii, Rosa majalis, Rosa spinosissima, Rosa x pruhoniciana, Rosa rugosa"Sara van fleet", Rosa rugosa"Souvenir de philemon cochet", Rosa Moyesi,essences from Africa and the Canary islands such as Anagallis arvensis, Musa x paradisiacal"nana, Erica arborea, Plumbago auriculata, Eucalyptus globules, Monstera deliciosa, Sonchus acaulis, Geranium peiforatum, K9, Canarina Canariensis, Artemisia arvensis, Cocos nucifera, Mimosa pudica, Echium vulgare, Strelitzia reginae, Narcissus tazetta, Hibiscus rosa sinensis, Echium wil < et i, Euphorbia pulcherrima and Cistus albidus ; and wild flower essences such as Aloe vera, Arnica montana, Ocimum basilicum, Borago officinalis, Pnunella vulgaris, Ranunculus acris, Iris germanica, Hypericum perforatum, Verbascum thapsus, Lavandula officinalis, Taraxacu officinale, Viscum album, Rosmarinus o-fll'cinalis.

Trifolium pratense, Achillea millefolium, Helianthus annuus, Dicentra spectabi/is, Viola hirta, Myosotis sylvatica, Zinnia elegans, Valeriana officinalis, Rubus fructicosus, Zantedeschia aethiopica, Anethum graveolens, Lilium bulbferum, Bellis perennis, Matricaria chamomil/a, Polygonum bistorta, Cucurbita pepo, Nelumbo nucifera, Prunus amygdalus, Zea mays, Passiflora bryonioides, Ipomea purpurea, Achillea millefolium, Saivia officinalis, Epilobium angustifolium, Paradisea liliastrum, Allium angulosum, Daucus carota, Opuntia cardiospera, Seticereus icosagonus, Stapelia deshietiana, Rosa, Chinensis viridijlora, Ginkgo biloba, Citrus

limon, Geranium perforatum, Cananna cananersis, Narassus tuzetta, Hibiscus rosa-

sinensis, Cistus allidus, Achillea millefolum, Salvia officinalis, Vinca minor, Echinaecea purpurea, Jepun bali, Jepun jawa, Aloe striata, Allium ursinum, Tussilagofarara, Oewthera biennis, Capsicum annuum, Celendula officinalis, Mentha pulegium and Primula veris.

The preferred secondary flower essences are selected from Rosa canina, Echinocereus

scheeri, Pilosocereus pachycladus, Rosa x pruhoniciana, Rosa Moyesii, Canarina Canariensis, Strelitzia reginae, Aloe vera, Arnica montana, Prunella vulgaris, Zinnia elegans, Matricaria chamomilla, Nelumbo nucifera, Passiflora bryonioides, Paradise liliastrum, Rosa spinosissima, Hibiscus Rosa, Jepun bali, Jepun jawa, Rosa roxbourghii, Orbea variegata, Cocos nucifera, Opuntia cardiosperma and Lilium bulbiferum.

Suitable essential oils include those from Citrus reticulata, Chamaemelum, Geraniaceae such as Pelargonium gravea, Aurantium Bergamia, Lavandula angustiforlia, Rosa centifloria absolute, Jasminum officinale abs, Citrus paradisi, Cananga odorata, Buswellia sp., Citrus aurantifolia, riganum, Citrus aurantium, Cymbopogan martini, Ravensara aromatica, Santalum album, Santalum spicatum, Lavendula x intermedia, Cymbopogon citrates, Citrus reticulata, Melissa officinalis, and Citrus sinesnsis.

Phytolaits are plant milks that are rich in natural plant proteins, lipids and sugars.

They are useful, particularly in cream formulations to be applied to the skin, because they have skin-hydrating, moisturising and restructuring properties.

Suitable phytolaits can be extracted from acacia flowers (Robinia pseudo-acacia), almonds, aloe vera, apricots, barley, blond pea, coconut, copalba, grape seeds, green tea, jasmine flowers, lotus flowers, lupine flowers, nectarines, oats, palms, passional flowers, soybeans and walnuts.

Preferred phytolaits are extracted from acacia flowers and jasmine flowers.

The flower essences used in the present invention may be extracted from flowers using any known technique such as, for example the traditional Bach method in which the flowers are floated in a crystal bowl and left in sunlight for up to 2-3 hours.

Mixing with an equal volume of alcohol then preserves the resulting mother tincture.

Alternatively, a crystal method may be used in which the blooms are neither picked nor damaged. A mother tincture is obtained which is again preserved with an equal volume of alcohol. The alcoholic mother tincture is then generally used directly or in a diluted stock form.

The medicaments of the present invention may be taken internally or applied externally to the body. Externally, they may be used pure or, for example, in the form of a soapy or aqueous emulsion, in an alcoholic solution, in an oil base, as a liniment, in overall or localised bathing, and in the form of creams, balms, lotions and spritzers.

Internally, depending upon the case, dosage will vary between 5 and 20 drops of pure essence administered several times a day before or after meals, or between 20 and 30 drops of pure essence administered several times a day in water, under the tongue or directly on the wrist.

Preferably the medicament is in the form of a topical cream, such as a facial cream.

Typically the cream will comprise: one or more orchid flower essences, one or more secondary flower essences, one or more essential oils and one or more phytolaits.

The phytolaits are used to form a"base cream"and the flower essences, essential oils and any other ingredients are added to this. The amount of the one or more orchid flower essence is preferably in the range 0.5-15% by volume of the base cream. 1- 15% by volume is highly beneficial and 2-10% by volume is especially advantageous. These quantities are also typical for the amount of secondary flower essence used. The amounts of essential oil used are typical, such as from 0. 05- 5% by volume of the base cream, preferably 0.05-3% by volume and further preferably 0.1- 1% by volume. 0.2% by volume is especially advantageous.

In an alternative embodiment, the medicament of the invention may also be formulated as a body oil in which the amount of phytolait is either reduced or replaced by one or more monoils. A preferred monoil is Tahitian coconut oil. Again the flower essences and essential oils are added to the one or more monoils in the same % by volume amounts described above.

Other ingredients may also be optionally included in the topical cream formulations, for example, manuka honey, herbal and floral waters, crystals and gems and precious and semi precious metals such as gold and silver.

The present invention will now be described with reference to the following Examples.

Orchid flower essence-containing medicament Formulations 1-3 according to the present invention are detailed below. These were made using conventional methods which involve firstly forming a base cream from phytolait and then drop wise addition of the flower essences and essential oils in the amounts detailed below.

Formulation 1

Orchid essences (5% by vol.) : Epidendrum chioneum and Miltonia phalaenopsis Secondary flower essences (7% by vol.) : Arnica montana, Prunella vulgaris, Matriciaria chamomilla, Zinnia elegans, Rosa spinosissima, Hibiscus Rosa and Jepun bali, Essential Oils (0.2% by vol.) : Citrus reticulata, Chamaemelum, Pelargonium gravea, Aurantium

Bergamia and Lavandula angustiforlia. Formulation 2 :

Orchid essences (5% by vol.) : Epidendrum secundum and Oncidium sphacelatum Secondary flower essences (7% by vol. ) : Nelumbo nucifera, Rosa x pruhoniciana, Echinocereus scheeri, Aloe vera, Prunella vulgaris, Jepun jawa, Paradise lilastrum Essential Oils (0.2% by vol.) : Rosa centifloria absolute, Jasminum officinale abs, Pelargonium gravea and Citrus Paradisi Formulation 3

Orchid essences (5% by vol.) : Anguloa clowesii and Oncidium abortivum Secondary flower essences (7% by vol.) : Rosa Moyesii, Strelitzia reginae, Pilosocereus pachycladus, Prunella vulgaris, Aloe vera and Arnica montana Essential Oils (0.2% by vol): Rosa centifloria abs, Cananga odorat, Pelargonium gravea and Citrus paradisi

Formulation 4 according to the invention is a body oil formulation also made using conventional methods. The selected flower essences and essential oils in the amounts specified below were added drop wise to a base oil comprising Tahitian coconut oil with Gardinia flowers.

Formulation 4

Orchid essences (10% by vol.) : Anguloa clowesii, Oncidium abortivum, Cattleya warscewiczii and Amazonas Secondary flower essences (5% by vol.) : Rosa Moyesii, Strelitzia reginae, Passiflora bryonioides, Pilosocereus pachycladus, Prunella vulgaris, Aloe vera, Arnica montana, Rosa roxbourghii, Rosa moyesii, Orbea variegata, Opuntia cardiosperma and Lilium bulbiferum, Essential Oils (0.2% by vol.) : Rosa centifloria abs, Cananga odorata, Pelargonium gravea, Citrus paradisi and Cocos nucifera Determination of the efficacy of the medicaments to reduce stress The stress-relief efficacy of the medicaments according to the present invention was determined as follows. Test patients were chosen who were suffering from stress caused, for example, through illness, or as a result of their lifestyle or due to a temporary period of stress. Each one of Formulations 1 to 3 was formulated as an

aqueous topical cream and was administered to the patient's face. Formulation 4 was administered to the whole body of the patient. Commercially available flower essence products, namely,"Bach Rescue Cream", available for example, from Boots Pic and "FES Self Heal Cream", available for example, from Tesco Plc, were used as comparative formulations and were administered to the patient in accordance with the packaging instructions. The patients were then monitored over a one-month period and at the end of this period they were asked to give their opinions and observations on the performance of the formulation (s) administered to them.

Results Each patient expressed the view that the formulations of the invention helped them to become less stressed in comparison to using no cream/body oil and the comparative commercially available products.

Conclusions The medicament formulations according to the present invention that contain one or more orchid essences provide enhanced stress relief and mood enhancement compared with other commercially available non-orchid essence containing flower products.

Claims

Claims: 1. Use of one or more orchid essences in the preparation of medicaments for reducing stress levels.
2. Use according to claim 1 wherein the medicaments optionally comprise one or more secondary flower essences, one or more essential oils, one or more phytolaits and one or more monoils.
3. Use according to either of claims 1 or 2 wherein the one or more orchid essences are selected from Acineta superb, Amazonas, Epidendrum secundum, Miltonia phalaenopsis, Oncidium incurvum, Stanhopea wardii,

Oncidium lanceanum, Cymbidium lowianum, Epidendrumprismatocarpum, Oncidium lanceanum, Cymbidium lowianum, Epidendrum prismatocarpum, Cattleya wacew/ct, Vanda tricolor, Laeliocattleya hybr., Laeliocattleya anceps clara, Cattleya trianae, Oncidium abortivum, Paphiopedilum harrysianum, Paphiopedilum insigne, Epidendrum chioneum, Anguloa clowesii, Orchis mascula, Oncidium sphacelatum and Victoria amazonica.
4. Use according to claim 3 wherein the orchid essences are selected from Epidendrum secundum, Miltonia phalaenopsis, Epidendrum chioneum, Oncidium sphacelatum, Amazonas, Cattleya warscewiczii, Oncidium abortivum and Anguloa clowesii.
5. Use according to any preceding claim wherein the secondary essences are selected from Aesculus hippocastanum, Bromus ramosus, Rosa canina, Salix vitellina, RQ5 (Cherry plum, clematis, impatiens, Rock rose and Star of Bethlehem) and RQ8 (Cherry plum, clematis, impatiens, Rock rose, Star of

Bethlehem Lotus and Self-heal (prunella vulgaris)), Caralluma russelliana, Cereus peruvianus, Ceropegia fusca, Cleistocactus ritterei, Cleistocactus stausii, Echinocactus grusonii, Echinocereus scheeri, Echinopsis oxygona, Ferocactus schwarzii, Hylocereus undatus, Mammillaria rubrograndis, Myitillocactus geometrizans, Opuntia cardiosperma, Opuntia dejecta, Orbea variegata, Pilosocereus pachycladus, Selenicereus grandiflorns, Seticereus

<Desc/Clms Page number 11>

icosagonus, Stenocereus marginatus and Stopelia desmetiana, Rosa roxbourghii, Rosa majalis, Rosa spinosissima, Rosa x pruhoniciana, Rosa rugosa"Sara van fleet", Rosa rugosa"Souvenir de philemon cochet", Rosa Moyesii, Anagallis arvensis, Musa xparadisiacal"nana, Erica arborea, Plumbago auriculata, Eucalyptus globules, Monstera deliciosa, Sonchus acaulis, Geranium perforatum, K. 9, Canarina Canariensis, Artemisia arvensis, Cocos nucifera, Mimosa pudica, Echium vulgare, Strelitzia reginae, Narcissus tazetta, Hibiscus rosa sinensis, Echium wildpretii, Euphorbia pulcherrima and Cistus albidus, Aloe vera, Arnica montana, Ocimum basilicum, Borago officinalis, Prunella vulgaris, Ranunculus acris, Iris germanica, Hypericum perforatum, Verbascum thapsus, Lavandula officinalis, Taraxacu officinale, Viscum album, Rosmarinus officinalis, Trifolium pratense, Achillea millefolium, Helianthus annuus, Dicentra spectabilis, Viola hirta, Myosotis sylvatica, Zinnia elegans, Valeriana officina lis, Rubus fructicosus, Zantedeschia aethiopica, Anethum graveolens, Lilium bulbferum, Bellis perennis, Matricaria chamomilla, Poftonum bistorta, Cucurbitapepo, Nelumbo nucifera, Prunus amygdalus, Zea mays, Passiflora bryonioides, Ipomea purpurea, Achillea millefolium, Salvia officinalis, Epilobium angustifolium, Paradisea liliastrum, Allium angu/osum and Daucus carota.
6. Use according to claim 5 wherein the secondary flower essences are selected from Rosa canina, Echinocereus scheeri, Pilosocereus pachycladus, Rosa x pruhoniciana, Rosa Moyesii, Canarina Canariensis, Strelitzia reginae, Aloe vera, Arnica montana, Prunella vulgaris, Zinnia elegans, Matricaria chamomilla, Ne/umbo nucifera, Passiflora bryonioides, Paradisea liliastrum, Rosa spinosissima, Hibiscus rosa, Jepun bali, Jepunjawa, Rosa roxbourghii, Orbea variegata, Opuntia cardiosperma and Lilium bulbiferum.
7. Use according to any preceding claim wherein the amount of orchid essence in the medicament is from 0. 5 tol5% by volume based on the amount of phytolait and/or monoil.

<Desc/Clms Page number 12>
8. Use of a composition comprising Epidendrum chioneum, Miltonia

phalaenopsis, Arnica montana, Prunella vulgaris, Matriciaria chamomilla, Zinnia elegans, Rosa spinosissima, Hibiscus Rosa, Jepun bali, Citrus reticulata, Chamaemelum, Pelargonium gravea, Aurantium Bergamia and Lavandula angustiforlia in the preparation of medicaments for the treatment of stress.
9. Use of a composition comprising Epidendrum secundum, Oncidium sphacelatum, Nelumbo nucifera, Rosa x pruhoniciana, Echinocereus scheeri,

Aloe vera, Prunella vulgaris, Jepunjawa, Paradise lilastrum, Rosa centifloria absolute, Jasminum officinale abs, Pelargonium gravea and Citrus Paradisi in the preparation of medicaments for the treatment of stress.
10. Use of a composition comprising Anguloa clowesii, Oncidium abortivum, Rosa Moyesii, Strelitzia reginae, Passiflora bryonioides, Pilosocereus

pachycladus, Prunella vulgaris, Aloe vera, Arnica Montana, Rosa centifloria abs, Cananga odorata, Pelargonium gravea and Citrus paradisi in the preparation of medicaments for the treatment of stress.
11. Use of a composition comprising Anguloa clowesii, Oncidium abortivum, Cattleya warscewiczii, Amazonas, Rosa Moyesii, Strelitzia reginae, Passiflora bryonioides, Pilosocereus pachycladus, Prunella vulgaris, Aloe vera, Arnica montana, Rosa roxbourghii, Rosa moyesii, Orbea variegata, Opuntia cardiosperma, Lilium bulbiferum, Rosa centijloria abs, Cananga odorata, Pelargonium gravea, Citrus paradisi and Cocos nucifera in the preparation of medicaments for the treatment of stress.
12. A topical cream comprising one or more orchid essences.
13. A cream as claimed in claim 12, wherein the cream optionally contains one or more secondary flower essences.

<Desc/Clms Page number 13>
14. The cream according to either of claims 12 or 13 wherein the one or more orchid essences are selected from Acineta superba, Amazonas, Epidendrum secundum, Miltonia phalaenopsis, Oncidium incurvum, Stanhopea wardii, Oncidium lanceanum, Cymbidium lowianum, Epidendrum prismatocarpum, Cattleya warscewiczii, Vanda tricolor, Laeliocattleya hybr., Laeliocattleya anceps clara, Cattleya trianae, Oncidium abortivum, Paphiopedilum harrysianum, Paphiopedilum insigne, Epidendrum chioneum, Anguloa clowesii, Orchis mascula, Oncidium sphacelatum and Victoria amazonica.
15. The cream according to claim 14, wherein the orchid essences are selected from Epidendrum secundum, Miltonia phalaenopsis, Epidendrum chioneum, Oncidium sphacelatum, Amazonas, Cattleya warscewiczii, Oncidium abortuivum and Anguloa clowesii.
16. The cream according to any one of claims 13 to 15, wherein the secondary essences are selected from Aesculus hippocastanum, Bromus ramosus, Rosa canina, Salix vitellina, RQ5 (Cherry plum, clematis, impatiens, Rock rose and Star of Bethlehem) and RQ8 (Cherry plum, clematis, impatiens, Rock rose, Star of Bethlehem Lotus and Self-heal (Prunella vulgaris)), Caralluma russelliana, Cereus peruvianus, Ceropegiajusca, Cleistocactus ritterei, Cleistocactus stausii, Echinocactus grusonii, Echinocereus scheeri, Echinopsis oxygona, Ferocactus schwarzii, Hylocereus undatus, Mammillaria rubrograndis, Myitillocactus geometrizans, Opuntia cardiosperma, Opuntia dejecta, Orbea variegata, Pilosocereus pachycladus, Selenicereus grandiflorus, Seticereus icosagonus, Stenocereus marginatus and Stopelia desmetiana, Rosa roxbourghii, Rosa majalis, Rosa spinosissima, Rosa x pruhoniciana, Rosa rugosa "Sara vanfleet", Rosa rugosa "Souvenir de philemon c ch! C/", Rosa Moyesii, Anagallis arvensis, Musa x paradisiacal "nana, Erica arborea, Plumbago auriculata, Eucalyptus globules, Monstera deliciosa, Sonchus acaulis, Geranium perforatum, K9, Canarina Canariensis, Artemisia arvensis, Cocos nucifera, Mimosa pudica, Echium vulgare, Strelitzia reginae, Narcissus tazetta, Hibiscus rosa sinensis, Echium

<Desc/Clms Page number 14>

wildpretii, Euphorbiapulcherrima and Cistus albidus, Aloe vera, Amica montana, Ocimum basilicum, Borago o icinalis, Prunella vulgaris, Ranunculus acris, Iris germanica, Hypericum perforatum, Verbascum thapsus, Lavandula officinalis, Taraxacu officinale, Viscum album, Rosmarinus officinalis, Trifolium pratense, Achillea millefolium, Helianthus annuus, Dicentra spectabilis, Viola hirta, Myosotis sylvatica, Zinnia elegans, Valeriana officinalis, Rubus fructicosus, Zantedeschia aethiopica, Anethum graveolens, Lilium & M//erM Bellis perennis, Matricaria chamomilla, Polygonum bistorta, Cucurbita pepo, Nelumbo Prunus amygdalus, Zea mays, Passiflora bryonioides, Ipomea purpurea, Achillea millefolium, Salvia officinalis, Epilobium angustifolium, Paradisea liliastrum, Allium angulosum and Daucus carota.
17. The cream according to claim 16, wherein the secondary flower essences are selected from Rosa canina, Echinocereus scheeri, Pilosocereus pachycladus, Rosa xpruhoniciana, Rosa Moyesii, Canarina Canariensis, Strelitzia reginae, Aloe vera, Arnica Montana, Prunella vulgaris, Zinnia elegans, Matricaria chamomilla, Nelumbo nucifera, Passiflora bryonioides, Paradisea liliastrom, Rosa spinosissima, Herbiscus rosa, Jepun bali, Jepunjawa, Rosa roxbourghii, Orbea variegata, Opuntia cardiosperma and Lilium bulbiferum.
18. A cream or body oil formulated in accordance with any of Examples 1 to 4 described herein above.